Nassr Nassr
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 4
-
- Asthma and respiratory diseases 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
-
- Phosphodiesterase function and regulation 9
-
- Analytical Methods in Pharmaceuticals 3
-
- Heart Failure Treatment and Management 2
- Cardiac electrophysiology and arrhythmias 2
- Blood Pressure and Hypertension Studies 1
- Co-authors
- Gëzim LahuRóbert HermannOliver von RichterKarl ZechMagnus Ingelman‐SundbergRolf HerzogDietrich KnoerzerChristian de Mey
- Journals
- The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Nassr Nassr
13 papers receiving 336 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 141
- Physiology 108
- Pulmonary and Respiratory Medicine 104
- Transplantation 8
- Oncology 79
Countries citing papers authored by Nassr Nassr
This map shows the geographic impact of Nassr Nassr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nassr Nassr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nassr Nassr more than expected).
Fields of papers citing papers by Nassr Nassr
This network shows the impact of papers produced by Nassr Nassr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nassr Nassr. The network helps show where Nassr Nassr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nassr Nassr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2011 | 10 | |
| 3 | 2011 | 17 | |
| 4 | 2011 | 3 | |
| 5 | 2011 | 11 | |
| 6 | 2010 | 18 | |
| 7 | 2010 | 14 | |
| 8 | 2009 | 13 | |
| 9 | 2009 | 34 | |
| 10 | 2007 | 15 | |
| 11 | 2007 | 32 | |
| 12 | 2006 | 25 | |
| 13 | 2006 | 73 | |
| 14 | 2006 | 94 |
About Nassr Nassr
Nassr Nassr is a scholar working on Pharmacology, Transplantation and Analytical Chemistry, having authored 14 papers that have together received 359 indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (9 papers), Asthma and respiratory diseases (7 papers), Pharmacogenetics and Drug Metabolism (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Heart Failure Treatment and Management (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Pharmacology (141 citations), Physiology (108 citations) and Pulmonary and Respiratory Medicine (104 citations). Nassr Nassr has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Gëzim Lahu, Róbert Hermann, Oliver von Richter, Karl Zech, Magnus Ingelman‐Sundberg, Rolf Herzog, Dietrich Knoerzer, Christian de Mey, Beverly Lyn‐Cook and Daniel W. Nebert. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Expert Opinion on Drug Safety and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.